Jens Christian Jensenius
Founder at Helion Biotech ApS
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Per Bo Pedersen Fischer | M | - |
Helion Biotech ApS
Helion Biotech ApS Pharmaceuticals: MajorHealth Technology Helion Biotech ApS develops and manufactures drugs. It develops a recombinant human protein from the innate immune system (MASP-2) for therapeutic use in cancer. The firm's MASP-2 protein is used to prevent or treat infectious episodes in MASP-2 deficient patients undergoing chemotherapy. The company was founded by Jeppe Vesti Christensen, Per Bo Pedersen Fischer, Jens Christian Jensenius and Steffen Thiel in 2008 and is headquartered in Lyngby, Denmark. | 16 years |
Jesper Zeuthen | M | - |
University of Aarhus
| - |
Claus Vastrup | M | 82 |
University of Aarhus
| - |
Lars Henrik Fugger | M | 64 |
University of Aarhus
| 28 years |
Michael Christiansen | M | 79 |
University of Aarhus
| - |
Finn Skou Pedersen | M | - |
University of Aarhus
| - |
Mogens Ryttergård Duch | M | - |
University of Aarhus
| - |
Karl Møller Bek | M | - |
University of Aarhus
| - |
Sara Fevre Kindberg | M | - |
University of Aarhus
| - |
Karl Anker Jørgensen | M | 69 |
University of Aarhus
| - |
Caroline Søeborg Ahlefeldt-Laurvig-Bille | F | - |
University of Aarhus
| 5 years |
Børge Obel | M | 76 |
University of Aarhus
| 20 years |
Jon Steen Petersen | M | 77 |
University of Aarhus
| - |
Jeppe Vesti Christensen | M | - |
Helion Biotech ApS
Helion Biotech ApS Pharmaceuticals: MajorHealth Technology Helion Biotech ApS develops and manufactures drugs. It develops a recombinant human protein from the innate immune system (MASP-2) for therapeutic use in cancer. The firm's MASP-2 protein is used to prevent or treat infectious episodes in MASP-2 deficient patients undergoing chemotherapy. The company was founded by Jeppe Vesti Christensen, Per Bo Pedersen Fischer, Jens Christian Jensenius and Steffen Thiel in 2008 and is headquartered in Lyngby, Denmark. | 16 years |
Steffen Thiel | M | 63 |
Helion Biotech ApS
Helion Biotech ApS Pharmaceuticals: MajorHealth Technology Helion Biotech ApS develops and manufactures drugs. It develops a recombinant human protein from the innate immune system (MASP-2) for therapeutic use in cancer. The firm's MASP-2 protein is used to prevent or treat infectious episodes in MASP-2 deficient patients undergoing chemotherapy. The company was founded by Jeppe Vesti Christensen, Per Bo Pedersen Fischer, Jens Christian Jensenius and Steffen Thiel in 2008 and is headquartered in Lyngby, Denmark. | 16 years |
Anders Nykjaer | M | - |
University of Aarhus
| - |
Henrik Kagenow | M | - |
University of Aarhus
| - |
Peder Tuborgh | M | 61 |
University of Aarhus
| - |
Brian Bech Nielsen | M | 66 |
University of Aarhus
| 36 years |
Carsten Bjerg | M | 64 |
University of Aarhus
| - |
Nina Smith | F | 68 |
University of Aarhus
| - |
Connie Hedegaard Koksbang | F | 63 |
University of Aarhus
| 7 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Ole Bitsch-Jensen | M | - |
Helion Biotech ApS
Helion Biotech ApS Pharmaceuticals: MajorHealth Technology Helion Biotech ApS develops and manufactures drugs. It develops a recombinant human protein from the innate immune system (MASP-2) for therapeutic use in cancer. The firm's MASP-2 protein is used to prevent or treat infectious episodes in MASP-2 deficient patients undergoing chemotherapy. The company was founded by Jeppe Vesti Christensen, Per Bo Pedersen Fischer, Jens Christian Jensenius and Steffen Thiel in 2008 and is headquartered in Lyngby, Denmark. | 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
Denmark | 23 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jens Christian Jensenius
- Personal Network